Synergy Shield Coronary Stent 2.25 X 8 | REF H7493966608220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 8 mm, REF H7493966608220. Single-unit B2B catalog listing for hospital and cath lab procurement.
The Abbott Xience Xpedition Coronary Stent (REF 1070250-23) is a balloon-expandable, everolimus-eluting coronary stent system in a 2.50 mm diameter × 23 mm length configuration. It is supplied sterile for single use and is intended for catheter-based delivery in interventional cardiology procedures. This listing provides catalog information for qualified B2B purchasers and hospital supply chain teams.
Key Features
- Drug-eluting platform: Everolimus coating on a durable fluoropolymer-based matrix.
- Cobalt chromium alloy stent frame engineered for low profile and radial strength.
- Delivery system designed for enhanced deliverability, pushability and lesion access.
- Stent dimensions: 2.50 mm nominal diameter, 23 mm length.
- Sterile, single-use packaging for procedural readiness.
- Radiopaque markers to support fluoroscopic placement.
Clinical Applications
- Intended for use in percutaneous coronary intervention (PCI) workflows as defined by the manufacturer's Instructions for Use.
- Suitable sizing for small to mid-caliber coronary vessels where a 2.50 mm × 23 mm drug-eluting stent is indicated per physician assessment.
- Indications, contraindications, warnings and precautions: Refer to the official Abbott Xience Xpedition IFU. Not specified in the located sources beyond manufacturer labeling.
Product Information
- Brand: Abbott
- Product line: Xience Xpedition
- Category: Coronary Stents (Drug-Eluting)
- REF / UPN: 1070250-23
- Stent diameter: 2.50 mm
- Stent length: 23 mm
- Drug: Everolimus
- Stent material: Cobalt chromium alloy
- Delivery system length: Not specified in the located sources
- Guidewire compatibility: Not specified in the located sources
- Sterility: Sterile, single use
- Storage: Per manufacturer labeling
- Regulatory status: Refer to regional Abbott labeling and local regulatory authority; purchasers are responsible for verifying approval status in their market.
REF / UPN1070250-23
Size23 mm
Abbott Xience XpeditionXience Xpedition stentcoronary stent 2.50 x 23 mmeverolimus eluting stentdrug eluting stentREF 1070250-23Abbott coronary stentcobalt chromium stentPCI stentinterventional cardiology suppliesDES coronary stentballoon expandable stentXience DEScoronary artery stentmedical device procurement
Related Products
Related products from the same category
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 8 | REF H7493966608270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 8 mm (REF H7493966608270), available for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 8 | REF H7493966608300
Boston Scientific Synergy Shield Coronary Stent (3.00 mm x 8 mm), REF H7493966608300, supplied for B2B procurement.
Synergy Shield Coronary Stent 3.50 X 8 | REF H7493966608350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 8 mm (REF H7493966608350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 8 | REF H7493966608400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 8 mm (REF H7493966608400) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 12 | REF H7493966612220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 12 mm (REF H7493966612220) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.50 X 12 | REF H7493966612250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 12 mm (REF H7493966612250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 12 | REF H7493966612270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 12 mm (REF H7493966612270) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 12 | REF H7493966612300
Boston Scientific Synergy Shield Coronary Stent, 3.00 mm x 12 mm (REF H7493966612300) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.50 X 12 | REF H7493966612350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 12 mm (REF H7493966612350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 12 | REF H7493966612400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 12 mm, REF H7493966612400, supplied for B2B procurement.
Synergy Shield Coronary Stent 4.50 X 12 | REF H7493966612450
Boston Scientific Synergy Shield Coronary Stent, 4.50 mm x 12 mm (REF H7493966612450) for B2B medical device procurement.
Synergy Shield Coronary Stent 5.00 X 12 | REF H7493966612500
Boston Scientific Synergy Shield Coronary Stent, 5.00 mm x 12 mm (REF H7493966612500), supplied for B2B medical device procurement.
Buyer support
Frequently asked questions about Xience Xpedition Coronary Stent 2.50 × 23 mm | REF 1070250-23
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.